Improving endothelial cell adhesion and proliferation on titanium by sol-gel derived oxide coating

Journal of Biomedical Materials Research - Part A

Volumn 92, Issue 2, 2010, Pages 754-765

  Chai, Feng ^a   Ochsenbein, Anne ^b,c   Traisnel, Michel ^c   Busch, Ralf ^b   Breme, Jürgen ^b   Hildebrand, Hartmut F ^a  

^a UNIV LILLE   (France)

^b SAARLAND UNIVERSITY   (Germany)

^c Ecole Nationale Superieure de Chimie de Lille   (France)

Author keywords

Endothelial stent seeding; Endothelialization; Sol gel coating; Stent; Titanium

Indexed keywords

ATOMIC FORCE MICROSCOPY; CELL ADHESION; CELL CULTURE; ENDOTHELIAL CELLS; NIOBIUM OXIDE; PROTECTIVE COATINGS; SILICA; SOL-GEL PROCESS; SOL-GELS; STENTS; SURFACE CHEMISTRY; TITANIUM; TITANIUM DIOXIDE; TITANIUM METALLOGRAPHY;

COMMERCIAL PURE TITANIUM; ENDOTHELIALIZATION; MICROVASCULAR ENDOTHELIAL CELLS; NANOPOROUS STRUCTURES; PHYSIO-CHEMICAL PROPERTIES; SOL-GEL COATINGS; STENT; THERAPEUTIC STRATEGY;

TITANIUM OXIDES;

SILICON DIOXIDE; TITANIUM; TITANIUM DIOXIDE;

ARTICLE; BIOCOMPATIBILITY; CELL ADHESION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MATERIAL COATING; PROTEIN EXPRESSION; STENT; SURFACE PROPERTY;

EID: 75149186006     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32399     Document Type: Article

References (53)

1. Hallisey MJ, Parker BC, van Breda A. Current status and extended applications of intravascular stents. Curr Opin Radiol 1992;4:7-12.
2. Fan CM, Rafferty EA, Geller SC, Kaufman JA, Brewster DC, Cambria RP, Waltman AC. Endovascular stent-graft in abdominal aortic aneurysms: The relationship between patent vessels that arise from the aneurysmal sac and early endoleak. Radiology 2001;218:176-182.
3. Hoffmann R, Mintz GS, Dussaillant GR, Popma JJ, Pichard AD, Satler LF. Patterns and mechanisms of in-stent restenosis - A serial intravascular ultrasound study. Circulation 1996;94:1247-1254.
4. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323.
5. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgio GM, Stankovic G. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-2130.
6. Vermeersch P, Agostoni P, Verheye S, van den Heurvel P, Convens C, Bruining N, van den Branden F, van Langenhove G. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: Six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC trial. J Am Coll Cardiol 2006;48:2423-2431.
7. Vermeersch P, Agostoni P, Verheye S, van den Heurvel P, Convens C, van den Branden F, van Langenhove G; for the DELAYED RRISC (Death and Events at Long-term follow-up Analysis: Extended Duration of the Reduction of Restenosis in Saphenous Vein Grafts with Cypher Stent) Investigators. Increased late mortality after sirolimuseluting stents versus bare-metal stents in diseased saphenous vein grafts: Results from the randomized DELAYED RRISC trial. J Am Coll Cardiol 2007;50:261-267.
8. Okabe T, Lindsay J, Buch AN, Steinberg DH, Roy P, Slottow TL, Smith K, Torguson R, Xue Z, Satler LF, Kent KM, Pichard AD, Weissman NJ, Waksman R. Drug-eluting stents versus bare metal stents for narrowing in saphenous vein grafts. Am J Cardiol 2008;102:530-534.
9. Melfi R, Nusca A, Patti G, Di Sciascio G. The risks and benefits of drug-eluting stents in the setting of STEMI. Curr Cardiol Rep 2008;10:402-406.
10. Zhang F, Qian J, Ge J. Coexistent in-stent restenosis, late incomplete stent apposition and mural thrombus in a zotarolimus-eluting stent. J Invasive Cardiol 2008;20:423-425.
11. Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schomig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS. Outcomes associated with drug-eluting and bare-metal stents: A collaborative network meta-analysis. Lancet 2007;370:937-948.
12. Jensen LO, Maeng M, Kaltoft A, Thayssen P, Hansen HH, Bottcher M, Lassen JF, Krussel LR, Rasmussen K, Hansen KN, Pedersen L, Johnsen SP, Soerensen HT, Thuesen L. Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions. J Am Coll Cardiol 2007;50:463-470.
13. Kuchulakanti PK, Chu WW, Torguson R, Ohlmann P, Rha SW, Clavijo LC. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 2006;113:1108-1113.
14. Joner M, Nakazawa G, Finn AV, Quee SC, Coleman L, Acampado E, Wilson PS, Skorija K, Cheng Q, Xu X, Gold HK, Kolodgie FD, Virmani R. Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol 2008;52:333-342.
15. Zhao FH, Chen YD, Jin ZN, Lu SZ. Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents. Med Hypotheses 2008;70:512-514.
16. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202.
17. Shirota T, Yasui H, Shimokawa H, Matsuda T. Fabrication of endothelial progenitor cell (EPC)-seeded intravascular stent devices and in vitro endothelialization on hybrid vascular tissue. Biomaterials 2003;24:2295-2302.
18. Nishi S, Nakayama Y, Ueda-Ishibashi H, Matsuda T. Embolization of experimental aneurysms using a heparin-loaded stent graft with micropores. Cardiovasc Radiat Med 2003;4: 29-33.
19. Williams SKJB. Tissue-engineered vascular grafts. Nat Med 1996;2:32-34.
20. Zund G, Hoerstrup SP, Schoeberlein A. Tissue engineering: A new approach in cardiovascular surgery: Seeding of human fibroblasts followed by human endothelial cells on resorbable mesh. Eur J Cardiothorac Surg 1998;13:160-164.
21. De Scheerder IK, Wilczek KL, Verbeken EV, Vandorpe J, Lan PN, Schacht E, Piessens J, De Geerst H. Biocompatibility of biodegradable and nonbiodegradable polymer-coated stents implanted in porcine peripheral arteries. Cardiovasc Intervent Radiol 1995;18:227-232.
22. Viegas MF, Abrantes LM, Lecoeur J. Metal materials biodegradation: A chronoamperometric study. J Mater Sci: Mater Med 1990;1:105-109.
23. Breme J. Titanium and titanium alloys, biomaterials of preference. Revue de Métallurgie 1989;10:625-637.
24. Velten D, Eisenbarth E, Schanner N, Breme J. Biocompatible Nb2O5 thin films prepared by means of the sol-gel process. J Mater Sci Mater Med 2004;15:457-461.
25. Velten D, Biehl V, Aubertin F, Valeske B, Possart W, Breme J. Preparation of TiO2 layers on cp-Ti and Ti6Al4V by thermal and anodic oxidation and by sol-gel coating techniques and their characterization. J Biomed Mater Res 2002;59:18-28.
26. Kwok DY, Neumann AW. Contact angle measurements and interpretation: Wetting behavior and solid surface tensions for poly(alkyl methacrylate) polymers. J Adhes Sci Technol 2000;14:719-743.
27. Krump-Konvalinkova V, Bittinger F, Unger RE, Peters K, Lehr HA, Kirkpatrick CJ. Generation of human pulmonary microvascular endothelial cell lines. Lab Invest 2001;81:1717-1727.
28. Hornez JC, Lefèvre A, Joly D, Hildebrand HF. Multiple parameter cytotoxicity index on dental alloys and pure metals. Biomol Eng 2002;19:103-118.
29. Trochon V, Mabinate-Pragnon C, Bertrand P, Legrand Y, Soria J, Soria C, Delpech B, Lu H. Hyaluronectin blocks the stimulatory effect of the hyaluronan-derived fragments on endothelial cells during angiogenesis in vitro. FEBS Lett 1997;418:6-10.
30. Linez-Bataillon P, Monchau F, Bigerelle M, Hildebrand HF. In vitro MC3T3 osteoblast adhesion with respect to surface roughness of Ti6Al4V substrates. Biomol Eng 2002;19:133-142.
31. Seyfert UT, Biehl V, Schenk J. In vitro hemocompatibility testing of biomaterials according to the ISO 10993-4. Biomol Eng 2002;19:91-96.
32. Chrysicopoulou P, Davazoglou D, Trapalis C, Kordas G. Optical properties of SiO2-TiO2 sol-gel thin films. J Mater Sci 2004;39:2835-2839.
33. 5 films. J Vacuum Sci Tech 2005;23:241-247.
34. Colombo A, Hall P, Makamura S. Intracoronary stenting without anticoagulation accomplished with intravascular guidance. Circulation 1995;91:1676-1688.
35. Wilson SH, Rihal CS, Bell MR, Velianou JL, Holmes DR Jr, Berger PB. Timing of coronary stent thrombosis in patients treated with ticlopidine and aspirin. Am J Cardiol 1999; 83:1006-1011.
36. Topol EJ, Serruys PW. Frontiers in interventional cardiology. Circulation 1998;98:1802-1820.
37. Callow AD. Endothelial cell seeding: Problems and expectations. J Vasc Surg 1987;6:318-319.
38. Hildebrand HF. Metal and ceramic implants. In: Merian E, Anke M, Ihnat K, Stoeppler M, editors. Elements and Their Compounds in the Environment, Vol. 1: General Aspects. Weinheim: Wiley-VCH (ISBN3-527-30459-2); 2004. p 369-390.
39. Steinemann SG. Metal implants and surface reactions. Injury 1996;27 (Suppl 3):SC16-SC22.
40. Hong J, Andersson J, Ekdahl KN, Elgue G, Axen N, Larsson R, Nilsson B. Titanium is a highly thrombogenic biomaterial: Possible implications for osteogenesis. Thromb Haemost 1999; 82:58-64.
41. Kastrati A, Schömig A, Dirschinger J. Increased risk of restenosis after placement of gold-coated stents: Results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease. Circulation 2000;101:2478-2483.
42. Heublein B, Pethig K, Elsayed AM. Silicon carbide coating: A semiconducting hybrid design of coronary stents - A feasibility study. J Invas Cardiol 1998;10:255-262.
43. Hardhammar PA, van Beusekom HMM, Emmanuelson HU. Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries. Circulation 1996;93:423-430.
44. Stefanadis C, Toutouzas K, Tsiamis E, Kallikazaros I, Stratos C, Vlachopoulos C, Vavuranakis M, Toutouzas P. Implantation of stents covered by autologous arterial grafts in human coronary arteries: A new technique. J Invasive Cardiol 2000;12:7-12.
45. Eisenbarth E, Velten D, Breme J. Biomimetic implant coatings. Biomol Eng 2007;24:27-32.
46. Steele JG, McFarland C, Dalton BA, Johnson G, Evans MD, Howlett CR, Underwood PA. Attachment of human bone cells to tissue culture polystyrene and to unmodified polystyrene: The effect of surface chemistry upon initial cell attachment. J Biomater Sci Polym Ed 1993;5:245-257.
47. Diener A, Nebe B, Lüthen F, Becker P, Beck U, Neumann HG, Rychly J. Control of focal adhesion dynamics by material surface characteristics. Biomaterials 2005;26:383-392.
48. Critchley DR. Focal adhesions - the cytoskeletal connection. Curr Opin Cell Biol 2000;12:133-139.
49. Howlett CR, Evans MDM, Walsh WR, Johnson G, Steele JG. Mechanism of initial attachment of cells derived from human bone to commonly used prosthetic materials during cell culture. Biomaterials 1994;15:213-219.
50. Lu J, Rao MP, MacDonald NC, Khang D, Webster TJ. Improved endothelial cell adhesion and proliferation on patterned titanium surfaces with rationally designed, micrometer to nanometer features. Acta Biomater 2008;4:192-201.
51. Choudhary S, Haberstroh KM, Webster TJ. Enhanced functions of vascular cells on nanostructured Ti for improved stent applications. Tissue Eng 2007;13:1421-1430.
52. Eisenbarth E, Linez P, Biehl V, Velten D, Breme J, Hildebrand HF. Cell orientation and cytoskeleton organisation of ground titanium surfaces. Biomol Eng 2002;19:233-238.
53. Eisenbarth E, Velten D, Schenk-Meuser K, Linez P, Biehl V, Duschner H, Breme J, Hildebrand HF. Interactions between cells and titanium surfaces. Biomol Eng 2002;19: 243-250.